212 related articles for article (PubMed ID: 15638760)
1. Hypericin--the facts about a controversial agent.
Kubin A; Wierrani F; Burner U; Alth G; Grünberger W
Curr Pharm Des; 2005; 11(2):233-53. PubMed ID: 15638760
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Kiesslich T; Krammer B; Plaetzer K
Curr Med Chem; 2006; 13(18):2189-204. PubMed ID: 16918348
[TBL] [Abstract][Full Text] [Related]
3. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
4. Hypericin in cancer treatment: more light on the way.
Agostinis P; Vantieghem A; Merlevede W; de Witte PA
Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
[TBL] [Abstract][Full Text] [Related]
5. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
6. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
7. Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.
Miskovsky P
Curr Drug Targets; 2002 Feb; 3(1):55-84. PubMed ID: 11899265
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical characterization of an enzyme responsible for the formation of hypericin in St. John's wort (Hypericum perforatum L.).
Bais HP; Vepachedu R; Lawrence CB; Stermitz FR; Vivanco JM
J Biol Chem; 2003 Aug; 278(34):32413-22. PubMed ID: 12799379
[TBL] [Abstract][Full Text] [Related]
9. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P
Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus.
Butterweck V; Böckers T; Korte B; Wittkowski W; Winterhoff H
Brain Res; 2002 Mar; 930(1-2):21-9. PubMed ID: 11879791
[TBL] [Abstract][Full Text] [Related]
11. Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.
Olivo M; Du HY; Bay BH
Curr Clin Pharmacol; 2006 Sep; 1(3):217-22. PubMed ID: 18666746
[TBL] [Abstract][Full Text] [Related]
12. Hypericins as potential leads for new therapeutics.
Karioti A; Bilia AR
Int J Mol Sci; 2010 Feb; 11(2):562-94. PubMed ID: 20386655
[TBL] [Abstract][Full Text] [Related]
13. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of Hyp-1, a St. John's wort protein implicated in the biosynthesis of hypericin.
Michalska K; Fernandes H; Sikorski M; Jaskolski M
J Struct Biol; 2010 Feb; 169(2):161-71. PubMed ID: 19853038
[TBL] [Abstract][Full Text] [Related]
16. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
17. Hypericin-mediated photodynamic therapy for the treatment of cancer: a review.
Dong X; Zeng Y; Zhang Z; Fu J; You L; He Y; Hao Y; Gu Z; Yu Z; Qu C; Yin X; Ni J; Cruz LJ
J Pharm Pharmacol; 2021 Mar; 73(4):425-436. PubMed ID: 33793828
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Nahrstedt A; Butterweck V
J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
[TBL] [Abstract][Full Text] [Related]
20. A novel antioxidant role for ligandin behavior of glutathione S-transferases: attenuation of the photodynamic effects of hypericin.
Lu WD; Atkins WM
Biochemistry; 2004 Oct; 43(40):12761-9. PubMed ID: 15461448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
